Product Code: 3550
The global stroke management market is anticipated to witness substantial growth through 2032, owing to the rising count of cardiovascular disease cases worldwide. In addition, shifting patient preference towards minimally invasive procedures is also expected to shape industry outlook. Such surgical procedures, such as endovascular thrombectomy, have seen a marked rise across healthcare facilities as they yield satisfactory clinical results.
Technological advancements in the field of medical devices is expected to bolster industry revenues as well. Minimally invasive procedures such as stereotactic surgery, use advanced imaging-based surgical localization with a 3-D roadmap systems, which help identify the clot and the suitable method for its removal.
In their efforts to further enhance patient outcomes, many industry players have started to marry technology with innovative surgical procedures. For instance, Cerebrotech Medical Systems, a neurotechnology device firm, introduced a product called Cerebrotech Visor, a VIPS technology-based device for neurological evaluation.
The device also received a CE mark in Europe for measuring stroke-related bioimpedance asymmetry. The company is further researching the device's feasibility in certain brain pathologies including stroke.
The overall stroke management market landscape is classified into segments such as type, product, end-use, and regional landscape.
Based on type, the market is categorized into hemorrhagic, ischemic, transient ischemic attack (TIA), and others. The ischemic segment held the largest market share of over USD 30 billion in 2022, fueled by the rising cases of ischemic disease, especially among women.
In fact, as per the World Stroke Organization (WSO), women account for over half (51%) of all active cases of ischemic stroke globally. A 2020 study estimates that ischemic heart disease affects approximately 126 million people worldwide, which is 1.72% of the global population.
On the basis of product, the industry is bifurcated into diagnostic devices and therapeutic devices. The diagnostic devices segment is expected to witness substantial growth from 2023-2032, owing to increasing public health programs that encourage the population to undergo periodic screening examinations for the early detection of specific chronic diseases including cancer, cardiovascular diseases, and others.
Based on end-use, the industry is divided into ambulatory surgical centers, diagnostic centers, hospitals, and others. Amongst them, the diagnostic centers segment held a multi-billion revenue share in 2022, primarily owing to the rising occurrences of neurological and cardiovascular ailments across the globe.
As per CDC, every 34 seconds a person dies due to cardiovascular disease in the U.S. Many world governments are focusing on improving their diagnosis capabilities to prevent CVDs-related deaths.
Regionally, the industry is classified into Europe, Asia Pacific, North America, MEA, and LATAM. The North America stroke management industry accounted for a lion's share of the overall market landscape in 2022, on account of the region's robust healthcare sector.
Moreover, the sector is also witnessing a growing number of investments in recent years, which further shapes the regional outlook. Increasing per capita income of North America's female population and rising urbanization are expected to deliver an additional capacity for growth to the market.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Methodology
- 1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.6 Secondary
- 1.6.1 Paid sources
- 1.6.2 Unpaid sources
- 1.7 Primary
Chapter 2 Executive Summary
- 2.1 Stroke management industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 Product trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Stroke Management Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2018 - 2032 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing preference for minimally invasive procedures
- 3.3.1.2 Increasing prevalence of cardiovascular diseases worldwide
- 3.3.1.3 Technological advancement in stroke management
- 3.3.1.4 Rising geriatric population in developing economies
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Stringent regulatory framework
- 3.3.2.2 High cost of procedures
- 3.4 Growth potential analysis
- 3.4.1 By type
- 3.4.2 By product
- 3.4.3 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Regulatory landscape
- 3.7 Technology landscape and innovation, 2022
- 3.8 Porter's analysis, 2021
- 3.8.1 Bargaining power of suppliers
- 3.8.2 Bargaining power of buyers
- 3.8.3 Threat of new entrants
- 3.8.4 Threat of substitutes
- 3.8.5 Industry rivalry
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape
- 4.1 Introduction
- 4.2 Company matrix analysis, 2021
- 4.3 Strategy dashboard, 2021
Chapter 5 Stroke Management Market, By Type
- 5.1 Key segment trends
- 5.2 Ischemic
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3 Hemorrhagic
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4 Transient ischemic attack (TIA)
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Stroke Management Market, By Product
- 6.1 Key segment trends
- 6.2 Diagnostic devices
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.2 Magnetic resonance imaging (MRI)
- 6.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.3 Computed tomography scan (CT scan)
- 6.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.4 Electrocardiography
- 6.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.5 Carotid ultrasound
- 6.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.6 Cerebral angiography
- 6.2.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.2.7 Others
- 6.2.7.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3 Therapeutic devices
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.2 Stent retriever
- 6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.3 Surgical clips
- 6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.4 Embolic coils
- 6.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.5 Flow diverters
- 6.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.6 Aspiration catheters
- 6.3.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 6.3.7 Others
- 6.3.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Stroke Management Market, By End-use
- 7.1 Key segment trends
- 7.2 Hospitals
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.3 Ambulatory surgical centers
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.4 Diagnostic centers
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.5 Others
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Stroke Management Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.2.2 Market size, by type, 2018 - 2032 (USD Million)
- 8.2.3 Market size, by product, 2018 - 2032 (USD Million)
- 8.2.3.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.2.3.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.2.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.2.5 U.S.
- 8.2.5.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.2.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.2.5.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.2.5.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.2.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.2.6 Canada
- 8.2.6.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.2.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.2.6.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.2.6.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.2.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.3.2 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.3 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.3.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.3.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.5 Germany
- 8.3.5.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.5.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.5.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.6 UK
- 8.3.6.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.6.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.6.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.7 France
- 8.3.7.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.7.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.7.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.7.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.8 Italy
- 8.3.8.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.8.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.8.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.8.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.9.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.9.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.9.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.10 Russia
- 8.3.10.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.10.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.10.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.10.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.10.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.11 Poland
- 8.3.11.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.11.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.11.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.11.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.11.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.3.12 Netherlands
- 8.3.12.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.3.12.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.12.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.3.12.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.3.12.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.4.2 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.3 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.3.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.3.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.5 China
- 8.4.5.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.5.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.5.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.6 Japan
- 8.4.6.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.6.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.6.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.7 India
- 8.4.7.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.7.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.7.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.7.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.8 Australia
- 8.4.8.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.8.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.8.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.8.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.9 South Korea
- 8.4.9.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.9.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.9.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.9.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.10 Malaysia
- 8.4.10.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.10.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.10.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.10.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.10.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.11 Thailand
- 8.4.11.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.11.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.11.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.11.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.11.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.4.12 Indonesia
- 8.4.12.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.4.12.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.12.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.4.12.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.4.12.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.5.2 Market size, by type, 2018 - 2032 (USD Million)
- 8.5.3 Market size, by product, 2018 - 2032 (USD Million)
- 8.5.3.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.5.3.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.5.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5.5 Brazil
- 8.5.5.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.5.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.5.5.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.5.5.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.5.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5.6 Mexico
- 8.5.6.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.5.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.5.6.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.5.6.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.5.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.5.7 Argentina
- 8.5.7.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.5.7.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.5.7.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.5.7.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.5.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6 Middle East & Africa
- 8.6.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.6.2 Market size, by type, 2018 - 2032 (USD Million)
- 8.6.3 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.3.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.6.3.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.5 South Africa
- 8.6.5.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.6.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.5.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.6.5.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.6.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.6 Saudi Arabia
- 8.6.6.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.6.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.6.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.6.6.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.6.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.7 UAE
- 8.6.7.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.6.7.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.7.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.6.7.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.6.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
- 8.6.8 Qatar
- 8.6.8.1 Market size, by type, 2018 - 2032 (USD Million)
- 8.6.8.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.8.2.1 Market size, by diagnostic devices, 2018 - 2032 (USD Million)
- 8.6.8.2.2 Market size, by therapeutic devices, 2018 - 2032 (USD Million)
- 8.6.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
- 9.1 Abbott
- 9.1.1 Business overview
- 9.1.2 Financial data
- 9.1.3 Product landscape
- 9.1.4 Strategic outlook
- 9.1.5 SWOT analysis
- 9.2 Asahi Intecc CO., LTD
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Boston Scientific Corporation
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 GE Healthcare
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Johnson & Johnson
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 Medtronic
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 Penumbra, Inc.
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 Siemens AG
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 B. Braun Melsungen AG
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Koninklijke Philips N.V
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Integer Holdings Corporation
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 Kaneka Medix Corp
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Teleflex Incorporated
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
- 9.14 Silk Road Medical, Inc.
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 SWOT analysis